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Abstract FarR (formerly P30) has been identified as a fatty acid and fatty acyl-CoA responsive DNA-binding protein. It is encoded by the farR 
gene (g30) in the citric acid cycle gene cluster of E. coli (gltA-sdhCDAB-sucABCD-farR). The amplified FarR protein specifically bound to the farR 
promoter (P&J and exhibited weak binding to the citrate synthase and lipoamide dehydrogenase promoters. Binding at PfWR was abolished by 
long-chain fatty acids and their CoA thioesters. In DNaseI footprints, FarR binding at PfO,R p rotected two sites, each characterised by two related 
IO-bp direct repeats. It issuggested that FarR autoregulates farR expression and may modulate citric acid cycle expression i  response to long-chain 
fatty acids. 
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1. Introduction 
FarR is an uncharacterised member of the GntR family of 
transcriptional regulators. They share similar N-terminal 
amino acid sequences that are predicted to contain analogous 
DNA-binding helix-turn-helix motifs [l]. The family is named 
after GntR, the repressor of the gluconate operon (gntRKPZ) 
in Bacillus subtilis [2]. The family also includes the HutC regu- 
lators of histidine utilisation in Pseudomonas putida and 
Klebsiella aerogenes, the KorA regulator of conjugal plasmid 
transfer in Streptomyces, and five regulatory proteins of 
Escherichia coli: PdhR (formerly GenA), the repressor of the 
pyruvate dehydrogenase operon (pdhR-aceEF-lpd); FadR, the 
repressor of fatty acid degradation; LctR, a potential regulator 
of L-lactate utilisation encoded by the 1ctPRLI operon; PhnF, 
a potential regulator of alkylphosphonate uptake and metabo- 
lism; and FarR, an uncharacterised regulator that was formerly 
designated P30 [1,3,4]. 
The gene encoding FarR @rR, formerly g30) is situated 
adjacent to the major cluster of citric acid cycle genes at 16.5 
min on the E. coli linkage map (Fig. 1) and it was previously 
suggested that FarR may be involved in their regulation [1,5]. 
Support for this suggestion was strengthened when the related 
pdhR gene was shown to encode a transcriptional regulator for 
the downstream pyruvate dehydrogenase (PDH) complex 
genes, aceEF and lpd (Fig. 1) [3]. The farR gene converges on 
the sucABCD operon, in which the sucA and SUCB genes encode 
the specific Elo and E20 components of the 2-oxoglutarate 
dehydrogenase (ODH) complex [5]. The E3 component is en- 
coded by the lpd gene which supplies lipoamide dehydrogenase 
subunits for assembly into the independently-regulated ODH 
and PDH complexes [3,6] as well as for the glycine cleavage 
system [7]. The single Ipd gene is expressed from the pdh pro- 
moter (PM) as part of a polycistronic pdhR-aceEF-lpd tran- 
script, to satisfy the E3 requirements of the PDH complex, and 
separately from the lpd promoter (P,&, to meet the needs of the 
ODH complex and glycine cleavage system. It was thus envis- 
aged that other potential functions of FarR might be to coreg- 
ulate expression from P,pd with sucAB transcription, and like 
many transcriptional regulators, to regulate its own expression. 
*Corresponding author. Fax: (44) (742) 728697. 
During studies aimed at identifying the role of FarR, the 
protein was found to bind to DNA fragments containing the 
farR promoter but could be released by long-chain fatty acids 
and their CoA thioesters. A potential operator sequence was 
detected and the protein was redesignated FarR to denote its 
fatty acyl Iesponse. 
2. Experimental 
2.1. Bacterial strains and plasmiris 
DHSa [S] was the routine E. coli strain and JRG2904, a pGS701 
transformant of E coli BL21/;1DE3 (Novagen Inc), was used for IPTG- 
induced amplification of the FarR protein. The source of farR DNA 
was pGSl30 [9]. The farR coding region was enriched by PCR amplifi- 
cation using two primers: S243, 98CooATCCCATGGGACACAAGCC- 
C’*O; and S244, 88500M~oTCGAcTCGGTITCGACs62 (numbered 
according to [5] with superscripted mismatches), which simultaneously 
introduce an NcoI site at the initiation codon and a downstream SaZI 
site. The NcoI- and San-digested product was subcloned downstream 
of the IPTG-inducible T7 promoter in NcoI-XhoI digested pETl6b 
(Novagen Inc) to generate pGS701 (Fig. I), and the presence of the 
desired nucleotide sequence was confirmed by dideoxy sequencing with 
representative plasmids. The farR promoter clones were constructed by 
subcloning the 2.2 kb EcoRV fragment of pGS130 into pBluescript SK- 
to give pGS702 (Fig. I), and the 0.35 kb BclI-HincII fragment of 
pGS702 was subcloned into pUCl19 to create pGS709 (Fig. 1). The 
other promoter clones illustrated in Fig. 1 have been described previ- 
ously [lo]. 
2.2. Microbiological metho&, protein purification and FarR assay 
Strains were cultured aerobically in L broth with ampicillin (100 
&ml) when required. DNA was isolated and manipulated by standard 
methods [ll]. Protein was assayed by the Bradford method and the 
Laemmli method was used for SDS-PAGE. Gels were stained with 
Coomassie brilliant blue and the molecular weight markers (BDH) were 
(kDa): ovotransferrin (77), bovine serum albumin (66), ovalbumin (43) 
and carbonic anhydrase (30). A Bio-Profil image analyser (Vilber-Lour- 
mat) was used for densitometry. The FarR protein was purified from 
cell-free ultrasonic extracts of JRG2904 grown at 37“C, induced with 
IPTG (40 &ml) in late-logarithmic phase, and incubated for a further 
16 h at 25°C. The purification procedure was similar to that devised 
for PdhR [lo]. This involved heparin-agarose chromatography using 
buffer A (20 mM Tris-HCl, 1 mM EDTA, 1 mM MgCl,, 1 mM sodium 
azide, 1 mM DTT, 0.1 mM PMSF, 10% glycerol; pH 7.3) and a salt 
gradient with buffer B (A plus 0.5 M ammonium sulphate). Pooled 
fractions containing FarR were diluted 5-fold to minimise precipitation 
during dialysis and subjected to cation exchange chromatography using 
a Protein-Pak SP 15HR 1,000 A column (Millipore) with the same 
buffer gradient, and dialysis. The purification was monitored by 
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Fig. 1. Transcriptional organisation of genes encoding citric acid cycle enzymes and the PDH complex at 16.5 and 2.5 min in the E. coli linkage map. 
The genes (boxed), promoters (arrowed), regions of potential secondary structure, and DNA fragments cloned in specific plasmids, are indicated. 
Relevant restriction sites are: A, AhaIII; B, BarnHI; Bc, Bcfl; Bg, BglI; Bs, BspAI; E, EcoRI; EC, EcoRV; H, HindHI; Hi, ZfincII; K, E@nI; M, 
engineered NcoI; P, PSI; R, RsaI; [Sal, engineered San; and X, XhoI; the subscript (3 refers to flanking vector sites used in subcloning. 
SDS-PAGE and by estimating the specific gel-retardation activity of 
fractions (units/pg protein) where one unit completely retards 1 pmol 
off&-R promoter DNA under standard conditions. 
2.3. Gel retardation and DNaseIfootprinting 
Gel retardation assays [12] were performed by incubating reaction 
mixtures (15 ~1) containing, 0.1 pmol of DNA (end-labelled with [a- 
“S]dATP), 5-200 ng of FarR protein, 3 ~1 of 5 x bandshift buffer, and 
1 pg poly(dI-dC) . poly(dI-dC), for 11 min at 37°C prior to fractionation 
by native PAGE and autoradiography. Potential coeffectors (5 mM) 
were added one minute before fractionation. Fatty acids and their CoA 
thioesters were from Sigma. DNaseI footprinting [12] involved incubat- 
ing 10-500 ng FarR protein with 2 pmol of DNA (end-labelled with 
[a-‘5S]dATP), 4 ~1 of 5 x binding buffer and 1 pg poly(dI-dC) .poly(dI- 
dC) in a total volume of 20 ~1, for 10 min at 37°C prior to digestion 
with 1~1 of 1 U/ml DNaseI (Boehringer Mannheim) for 2 min at 37°C. 
After phenol/chloroform extraction and ethanol precipitation, the en- 
tire sample was fractionated in a 5% acrylamide 7 M urea sequencing 
gel and analysed by autoradiography. 
3. Results and discussion 
3.1. Overproduction and partial purification of FarR 
The 32 kDa FarR protein was the only pGS701-specific 
Table 1 
Purification of FarR from E. coli JRG2904 
Fraction Total protein Purity 
bn) (%I 
product detected in protein-stained SDS-PAGE gels of induced 
cultures of JRG2904 compared to vector-containing controls. 
It was amplified to 25% of total cell protein in cultures induced 
at 37”C, but was totally insoluble. However, it accumulated to 
18% of total cell protein after induction at 25°C and as much 
as one third was soluble. This FarR fraction amounted to 10% 
of the protein in the soluble cell-free extract and it corresponds 
to an enrichment of at least 100-fold, because no band having 
the same mobility could be detected in comparable extracts of 
the vector-containing strain. The FarR protein was enriched a 
further 2.5-fold in two chromatographic steps, which removed 
most of the contaminants (Fig. 2; Table 1). Elution of the 32 
kDa protein correlated exacty with the gel-retardation activity 
(see section 3.2). Unfortunately, FarR had a great tendency to 
precipitate, which is reflected in the poor yield (0.2%) and the 
failure to achieve a purity greater than 25% (Table 1). The final 
product contained very few contaminants, but it could not be 
concentrated beyond 40 pg protein/ml (S-fold) without precip- 
itation, even in the presence of detergents uch as Genapol, 
Triton X-100, Tween-20 and Tween-80 at up to 0.5% W/V. The 
DNA-binding activity of the purified material disappeared 
bg) 
FarR protein 
(%I 
Recovery Specific activitya 
(U&g protein) 
Cell-free extract 176.0 10.1 17.8 100.0 2.4b 
Heparin 5.9 21.6 1.26 7.1 5.1 
Cation exchange 0.16 25.0 0.04 0.2 6.0 
“One unit of DNA-binding activity (U) is defined as the amount hat completely retards 1 pmol offarR promoter DNA under standard gel retardation 
conditions. 
bThe specific activity of a comparable xtract of the vector-containing wild-type strain was estimated as CO.024 U/pg protein. 
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during attempts at further purification, but declined by only 
50% when stored for 2 months at 4°C. 
3.2. DNA-binding studies with purified FarR protein 
Good DNA-binding activity was observed in gel retardation 
experiments with the 2.2 kb EcoRI-Hind111 fragment of 
pGS702 containing the farR promoter, PfarR (Fig. 3A). The 
apparent dissociation constant (I&) based on the amount of 
FarR that binds half of the PforR fragments under test condi- 
tions, was 1 x 10e9 M, assuming that two monomers bind to 
each site and allowing for the impurity of FarR. Comparable 
preparations were purified from induced cultures of strains 
containing the expression vector (pET16b) with no farR coding 
region. These preparations contained all of the proteins that 
contaminate partially-purified FarR but totally lacked DNA- 
retardation activity. This confirms that the observed DNA- 
binding activity is specific to FarR. The extremely remote pos- 
sibility that the activity arises as a secondary consequence of 
FarR overproduction is very unlikely, especially as it would 
also have to copurify with FarR. 
A total of 120 compounds including all of the citric-acid- 
cycle intermediates and 20 amino acids, were tested for their 
ability to abolish FarR-binding to the PfarR fragment. Only the 
long-chain fatty acids, C12:O to C18:O (Fig. 3B) and the corre- 
sponding acyl-CoA derivatives, behaved like potential coeffec- 
tors. The most effective members of each group, based on the 
concentrations needed for half-maximal FarR release, were the 
C16:O compounds, palmitic acid (1.50 mM) and palmitoyl- 
CoA (0.35 mM). No release was observed with the correspond- 
ing C12:O to C16:O methyl esters and primary alcohols, or with 
the Cl4 to Cl8 unsaturated fatty acids (myristoleic, pahnitoleic, 
oleic, linoleic and linolenic). The observed specificity suggests 
that the coeffectors are not simply acting as detergents and this 
was supported by the fact that Triton X-100 and Tween-20 
(~2% w/v) had no effect on DNA-binding by FarR. 
In analogous gel retardation experiments with DNA frag- 
ments containing the citric-acid-cycle and PDH-complex pro- 
moters illustrated in Fig. 1, faint but reproducible retarded 
bands were detected with purified FarR and fragments contain- 
ing Plpd, PglrA and Psdh, but not with those containing Ppdh, P,,, 
and P,,,, or with protein samples from the vector control (not 
shown). 
3.3. IdentiJication of the FarR operator sequence 
Further digests of pGS702 (P,,,& pGS704 (P,J and pGS708 
(P&4 and Psdh) were used in gel retardation studies to locate the 
FarR binding sites with greater precision. The P/orR site was 
traced to a 350 bp BclI-HincII fragment (Fig. 1) which was later 
incorporated in pGS709 for use in DNaseI footprinting (see 
below). Likewise, the P,p, site was located in a 550 bp R,saI 
fragment containing the aceF-lpd intergenic region, and the site 
in pGS708 was traced to a 250 bp EcoRV-BarnHI fragment 
containing DNA that lies just downstream of the gZtA promot- 
ers [13] (Fig. 1). 
The FarR binding site in P/arR was sought by DNaseI foot- 
printing with the 360 bp EcoRI-Hind111 fragment of pGS709 
(Fig. 4). Two AT-rich sites, each associated with two hypersen- 
sitive positions, were protected (Fig. 4A). The best protected 
or primary site, overlaps the predicted farR promoter in a 
region that contains several TAlTT and G/~TATT motifs, but 
no regions of hyphenated dyad symmetry of the type often 
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Fig. 2. Purification of FarR. (A) Typical elution profiles for (i) heparin- 
agarose and (ii) cation exchange chomotography (see 2.2 and Table 1) 
are shown with: absorbance at 280 nm (-); the ammonium sulphate 
gradient, 9% buffer B ( - - - - ); and DNA-binding activity expressed as a 
percentage of the most active fraction (M.. . n ). The open bar denotes 
the fractions retained after each step. (B) SDS-PAGE analysis of sam- 
ples from each stage of the purification: lane 1, molecular weight mark- 
ers (kDa); 2, cell-free extract; 3, heparin-agarose chromatography; 
4, cation exchange chromatography. 
associated with operator sites (Fig. 4B). However, the primary 
site is located in a 21-bp segment containing two lo-bp se- 
quences that differ at only two positions, 29TGTATTGTAT38 -- 
and 40TGTATTAT_TT49 “?GGTTAAAlTs3 and 84CGTAT- 
TAATG93, form a direct repeat associated with a secondary 
binding site that overlaps the ribosomal binding site (Fig. 4B). 
The four sequences are identical to a TGTATTA*/TTT 
consensus at seven or more positions, and it would appear that 
FarR binding sites contain two such tandemly-repeated se- 
quences. The three hypersensitive sites at positions 64, 66 and 
67, are interesting (Fig. 4). They could be due to DNA-bending 
caused by interactions between FarR molecules bound at each 
of the flanking DNA-binding sites, but it is not known whether 
this is physiologically significant or simply consequence of 
FarR’s known tendency to aggregate. No FarR-protected re- 
gions could be detected in DNaseI footprints of the weakly- 
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Fig. 3. FarR gel retardation studies with thefarR promoter fragment. (A) End-labelled DNA (0.1 pmol) from EcoRI-Hind111 digested pGS702 was 
incubated with purified FarR: 1, no FarR protein; 2, 5 ng; 3, 50 ng. (B) Potential coeffectors (5 mM) were incubated with 5 ng FarR protein and 
end-labelled P,o,R as above: 1, no FarR; 2, FarR; 3, FarR + capric acid (ClO:O); 4, FarR + lauric acid (Cl2 : 0); 5, FarR + myristic acid (C14: 0); 
6, FarR + palmitic acid (Cl6:O); 7, FarR + stearic acid (Cl8:O); 8, FarR + arachidic acid (C20: 0). The vector fragment (v), derives from pUCl19 
and the retarded PlnrR fragments (2.2-kb) are arrowed. 
retarded P,pd and PglrA fragments promoter, possibly because 
FarR could not be supplied in a sufficiently concentrated form. 
The relevant fragments contain single sequence motifs that 
resemble the consensus at seven or more positions: 
TTTGTTGTTT, overlapping the -35 hexamer of Phd; 
GGTATTACTT, at +23 to 32 in the lpd transcript: and 
TTTTTTATTT, 80 bp upstream of the translational start in the 
gltA transcript [6,13]. 
A B 
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GAATTC. 
BCll 
..TGATCAAT 
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10 
Ti 
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Fig. 4. DNaseI footprint analysis and nucleotide sequence of the farR promoter region. (A) DNA, labelled on the coding strand at the upstream 
EcoRI site was incubated with FarR protein: lane 1, no protein; 2,4 ng; 3,15 ng; 4,30 ng; 5,100 ng; prior to digestion with DNaseI and fractionation 
in a 5% acrylamide-urea gel with a dimethylsulphate digest of the same DNA fragment. (B) The sequence is numbered from the BclI site used in 
the initial cloning [5], just downstream of the vector EcoRI site labelled in pGS709 digests. The -10 and -35 elements of the predictedfarR promoter 
[5], the ribosome binding site (RBS), the FarR-protected regions (bracketed or shaded) and the hypersensitive sites (asterisked), indicated. The direct 
repeats at the FarR binding sites approximating to the TGTATTA*/TTT consensus (bold arrows), other repeated motifs, TAm (overlined) and 
G/~TATT (underlined), and potentially significant regions of dyad symmetry (converging arrows), are also indicated. 
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3.4. Conclusion 
The FarR protein was purified to 25% homogeneity from a 
soluble source that was enriched by at least lot&fold. Specific 
binding at two sites containing tandem repeats similar to 
TGTATTA*/TTT, was detected in the furR promoter region. 
Their locations indicate that FarR negatively autoregulates its 
own synthesis in response to long-chain fatty acid deficiency, 
by binding at these operator sites. The coeffector specificity of 
FarR resembles that of the FadR protein of E. coli, which 
represses fatty acid degradation genes, activates a fatty acid 
biosynthesis gene @bA), and is thought to have a role in regu- 
lating the glyoxylate cycle operon, aceBAK [14]. FadR is re- 
leased from its operators by fatty acyl-CoA thioesters (rC12), 
palmitoyl-CoA being the most effective [15]. The FadR bind- 
ing-site consensus, ACCTGGTCAGACGTGTG [14], contains 
a repeated AC-TG, but bears no resemblance to the FarR-site. 
The weak retardations observed with FarR and Phd and PBn, 
fragments could mean that FarR modulates expression of the 
citric acid cycle in response to long-chain fatty acid synthesis, 
but further work will be needed to define the nature and phys- 
iological significance of these interactions, and to identify other 
potential members of the FarR regulon. 
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